南光化學製藥股份有限公司
南光化學製藥股份有限公司（Nang Kuang Pharmaceutical Co., Ltd.）製造銷售注射液、抗老化藥物、癌症化療藥物及醫療器材。產品涵蓋心血管、神經與呼吸系統領域。公司成立於 1963 年，總部位於台灣台南。
該股 RSI(6) 為 56.9，處於中性區間，短線無明顯超買超賣訊號。股價站上5日、20日均線，跌破60日、120日均線。KD 指標中性（K=68.3）；MACD 柱狀體為正值，維持多方動能。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 08-10 | +17 | 0 | -1 | +16 |
| 08-07 | +20 | 0 | +7 | +27 |
| 08-06 | +2 | 0 | 0 | +2 |
| 08-05 | +1 | 0 | 0 | +1 |
| 08-04 | +5 | 0 | -9 | -4 |
| 08-03 | +6 | 0 | -2 | +4 |
| 07-31 | +17 | 0 | +1 | +18 |
| 07-30 | +3 | 0 | -4 | -1 |
| 07-29 | +7 | 0 | -1 | +6 |
| 07-28 | +2 | 0 | +4 | +6 |
| 07-27 | +2 | 0 | +1 | +3 |
| 07-24 | -1 | 0 | 0 | -1 |
| 07-23 | 0 | 0 | 0 | 0 |
| 07-22 | +4 | 0 | -1 | +3 |
| 07-21 | +11 | 0 | 0 | +11 |
| 07-20 | +9 | 0 | +2 | +11 |
| 07-17 | -31 | 0 | 0 | -31 |
| 07-16 | +9 | 0 | 0 | +9 |
| 07-15 | +6 | 0 | 0 | +6 |
| 07-14 | -26 | 0 | +2 | -24 |
| 07-13 | -25 | 0 | -3 | -28 |
| 07-09 | -22 | 0 | +1 | -21 |
| 07-08 | -14 | 0 | +2 | -12 |
| 07-07 | -13 | 0 | 0 | -13 |
| 07-06 | -1 | 0 | 0 | -1 |
| 07-03 | +15 | 0 | 0 | +15 |
| 07-02 | +4 | 0 | 0 | +4 |
| 07-01 | -35 | 0 | 0 | -35 |
| 06-30 | -15 | 0 | -2 | -17 |
| 06-29 | +6 | 0 | 0 | +6 |
| 06-26 | -19 | 0 | -1 | -20 |
| 06-25 | +1 | 0 | 0 | +1 |
| 06-24 | -1 | 0 | +5 | +4 |
| 06-22 | -30 | 0 | +2 | -28 |
| 06-18 | +8 | 0 | -1 | +7 |
| 06-17 | -6 | 0 | -3 | -9 |
| 06-16 | -7 | 0 | 0 | -7 |
| 06-15 | -1 | 0 | +1 | 0 |
| 06-12 | 0 | 0 | +4 | +4 |
| 06-10 | -23 | 0 | -1 | -24 |
| 06-09 | -43 | 0 | -1 | -44 |
| 06-08 | -74 | 0 | 0 | -74 |
| 06-04 | -1 | 0 | 0 | -1 |
| 06-03 | +16 | 0 | 0 | +16 |
| 06-02 | +8 | 0 | 0 | +8 |
| 06-01 | -6 | 0 | 0 | -6 |
| 05-29 | +64 | 0 | 0 | +64 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/06 | 1.55 億 | -17.0% | -18.1% |
| 2026/05 | 1.87 億 | -5.1% | +7.5% |
| 2026/04 | 1.97 億 | +21.6% | +10.2% |
| 2026/03 | 1.62 億 | +3.7% | -14.2% |
| 2026/02 | 1.56 億 | -26.4% | -20.0% |
| 2026/01 | 2.12 億 | +19.7% | +8.2% |
| 2025/12 | 1.77 億 | +16.2% | -10.6% |
| 2025/11 | 1.52 億 | -18.8% | -7.7% |
| 2025/10 | 1.88 億 | -0.8% | -13.1% |
| 2025/09 | 1.89 億 | +25.8% | +0.3% |
| 2025/08 | 1.51 億 | -18.1% | -18.8% |
| 2025/07 | 1.84 億 | - | -10.7% |